GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » C21 Investments Inc (XCNQ:CXXI) » Definitions » EV-to-EBITDA

C21 Investments (XCNQ:CXXI) EV-to-EBITDA : 21.64 (As of May. 26, 2024)


View and export this data going back to 1987. Start your Free Trial

What is C21 Investments EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, C21 Investments's enterprise value is C$65.45 Mil. C21 Investments's EBITDA for the trailing twelve months (TTM) ended in Oct. 2023 was C$3.03 Mil. Therefore, C21 Investments's EV-to-EBITDA for today is 21.64.

The historical rank and industry rank for C21 Investments's EV-to-EBITDA or its related term are showing as below:

XCNQ:CXXI' s EV-to-EBITDA Range Over the Past 10 Years
Min: -13.99   Med: -0.61   Max: 48.12
Current: 21.64

During the past 13 years, the highest EV-to-EBITDA of C21 Investments was 48.12. The lowest was -13.99. And the median was -0.61.

XCNQ:CXXI's EV-to-EBITDA is ranked worse than
70.07% of 715 companies
in the Drug Manufacturers industry
Industry Median: 14.42 vs XCNQ:CXXI: 21.64

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-26), C21 Investments's stock price is C$0.455. C21 Investments's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Oct. 2023 was C$-0.041. Therefore, C21 Investments's PE Ratio for today is At Loss.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


C21 Investments EV-to-EBITDA Historical Data

The historical data trend for C21 Investments's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

C21 Investments EV-to-EBITDA Chart

C21 Investments Annual Data
Trend Jan14 Jan15 Jan16 Jan17 Jan18 Jan19 Jan20 Jan21 Jan22 Jan23
EV-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only -4.02 -3.85 28.82 3.42 5.82

C21 Investments Quarterly Data
Jan19 Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.95 5.82 7.39 11.83 17.48

Competitive Comparison of C21 Investments's EV-to-EBITDA

For the Drug Manufacturers - Specialty & Generic subindustry, C21 Investments's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


C21 Investments's EV-to-EBITDA Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, C21 Investments's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where C21 Investments's EV-to-EBITDA falls into.



C21 Investments EV-to-EBITDA Calculation

C21 Investments's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=65.453/3.025
=21.64

C21 Investments's current Enterprise Value is C$65.45 Mil.
C21 Investments's EBITDA for the trailing twelve months (TTM) ended in Oct. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$3.03 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


C21 Investments  (XCNQ:CXXI) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

C21 Investments's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=0.455/-0.041
=At Loss

C21 Investments's share price for today is C$0.455.
C21 Investments's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Oct. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-0.041.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


C21 Investments EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of C21 Investments's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


C21 Investments (XCNQ:CXXI) Business Description

Traded in Other Exchanges
Address
601 West Cordova Street, Suite 280, Vancouver, BC, CAN, V6B 1G1
C21 Investments Inc is a vertically integrated cannabis company. It cultivates, processes, manufactures, and distributes cannabis and hemp-derived consumer products. C21's focus is to expand where the company can wholly own indoor or outdoor cultivation operations, extraction facilities, bakeries, branded products, and retail dispensaries with a large distribution network.
Executives
Bruce Macdonald Director

C21 Investments (XCNQ:CXXI) Headlines

No Headlines